We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$10.5B
AUM Growth
+$2.57B
Cap. Flow
+$2.52B
Cap. Flow %
23.97%
Top 10 Hldgs %
3.28%
Holding
3,782
New
851
Increased
1,449
Reduced
1,127
Closed
344

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$38.7M
2
AMZN icon
Amazon
AMZN
+$33.2M
3
IP icon
International Paper
IP
+$32.8M
4
XYZ
Block Inc
XYZ
+$32.6M
5
COF icon
Capital One
COF
+$30.7M

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$28M
2
DKS icon
Dick's Sporting Goods
DKS
+$27.9M
3
LLY icon
Eli Lilly
LLY
+$24.9M
4
MTN icon
Vail Resorts
MTN
+$24.7M
5
ACN icon
Accenture
ACN
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Financials 13.65%
3 Industrials 12.55%
4 Consumer Discretionary 12.48%
5 Healthcare 12.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRFS
3326
DELISTED
BRF SA
BRFS
$42K ﹤0.01%
+10,260
New +$41.9K
MIRM icon
3327
Mirum Pharmaceuticals
MIRM
$6.14B
$42K ﹤0.01%
2,649
-2,591
-49% -$40.3K
GOL
3328
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$42K ﹤0.01%
6,881
+6,622
+2,557% +$42.2K
AQB icon
3329
AquaBounty Technologies
AQB
$6.02M
$41K ﹤0.01%
+980
New +$63.1K
CTMX icon
3330
CytomX Therapeutics
CTMX
$754M
$40K ﹤0.01%
9,346
FLNA
3331
Filana Therapeutics
FLNA
$48.1M
$40K ﹤0.01%
918
-5,651
-86% -$296K
UONEK icon
3332
Urban One Class D
UONEK
$23.8M
$40K ﹤0.01%
1,168
-1,507
-56% -$73.7K
CLVS
3333
DELISTED
Clovis Oncology, Inc.
CLVS
$40K ﹤0.01%
14,800
-2,067
-12% -$7.64K
ATRS
3334
DELISTED
Antares Pharma, Inc.
ATRS
$40K ﹤0.01%
+11,329
New +$39.6K
CNCE
3335
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$39K ﹤0.01%
+12,254
New +$40.8K
EGY icon
3336
Vaalco Energy
EGY
$594M
$38K ﹤0.01%
+11,879
New +$39.4K
HOOK
3337
DELISTED
HOOKIPA Pharma
HOOK
$38K ﹤0.01%
1,629
-930
-36% -$37.4K
PANL icon
3338
Pangaea Logistics
PANL
$485M
$38K ﹤0.01%
+10,157
New +$43.1K
AKRO
3339
DELISTED
Akero Therapeutics
AKRO
$37K ﹤0.01%
1,747
-1,211
-41% -$26.9K
SIFY
3340
Sify Technologies
SIFY
$1.14B
$37K ﹤0.01%
+1,932
New +$39.3K
TK icon
3341
Teekay
TK
$985M
$37K ﹤0.01%
11,632
-21,210
-65% -$73.2K
LBTYA icon
3342
Liberty Global Class A
LBTYA
$3.6B
$36K ﹤0.01%
1,300
-15,425
-92% -$439K
PRDS
3343
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$36K ﹤0.01%
+2,206
New +$25.7K
EQOS
3344
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$36K ﹤0.01%
+19,494
New +$75.3K
ATHX
3345
DELISTED
Athersys, Inc. Common Stock
ATHX
$36K ﹤0.01%
+1,577
New +$45.2K
PEI
3346
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$36K ﹤0.01%
2,352
+474
+25% +$10.2K
WVE icon
3347
Wave Life Sciences
WVE
$1.2B
$35K ﹤0.01%
11,264
-5,638
-33% -$23.4K
OVID icon
3348
Ovid Therapeutics
OVID
$491M
$34K ﹤0.01%
10,604
-6,915
-39% -$23.7K
PPG icon
3349
PPG Industries
PPG
$26.6B
$34K ﹤0.01%
196
-69,102
-100% -$11.1M
IVR icon
3350
Invesco Mortgage Capital
IVR
$805M
$33K ﹤0.01%
1,173
-2,022
-63% -$62.6K

Similar funds

Cubist Systematic Strategies's Q4 2021 Portfolio in Review

As of Q4 2021, Cubist Systematic Strategies held 3,782 positions worth $10.5B, up 32% from $7.94B the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

Cubist Systematic Strategies deployed $2.52B of net new capital in Q4 2021, opening 851 new positions and adding to 1,449 existing holdings. Its largest new stake was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Estee Lauder, an estimated $28M trimmed.

  • Cubist Systematic Strategies's largest Q4 2021 buy was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.
  • Cubist Systematic Strategies added most to Medtronic in Q4 2021, an estimated $38.7M increase.
  • Cubist Systematic Strategies's biggest Q4 2021 reduction was Estee Lauder, cutting an estimated $28M.
  • Cubist Systematic Strategies fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $5.95M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.3% of its $10.5B portfolio in Q4 2021.
  • Cubist Systematic Strategies opened 851 new positions and closed 344 in Q4 2021.
  • Cubist Systematic Strategies's portfolio value rose 32% quarter-over-quarter to $10.5B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.